All Recalls

95,064 total recalls in our database

During internal review is was discovered that the incorrect dressing was used in production of a vegetable wrap that does not declare soy as an ingredient or allergen.

Dec 16, 2018 Produce View Details →

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Jan 18, 2019 Prescription Drugs Nationwide View Details →

CGMP Deviations; presence of extraneous material in the was observed in area that is between the primary package that is heat sealed and secondary packaging (poly-woven bag) of sucrose (an excipient) used in the finished product.

Jan 9, 2019 Prescription Drugs View Details →

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Jan 18, 2019 Prescription Drugs Nationwide View Details →

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Jan 18, 2019 Prescription Drugs Nationwide View Details →

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.

Jan 18, 2019 Prescription Drugs Nationwide View Details →